Epidemiological analysis of nasopharyngeal carcinoma in the central region of Japan during the period from 1996 to 2005

Auris Nasus Larynx

Volumn 38, Issue 2, 2011, Pages 244-249

  Kimura, Yuichi ^a   Suzuki, Dai ^a   Tokunaga, Takahiro ^a   Takabayashi, Tetsuji ^a   Yamada, Takechiyo ^a   Wakisaka, Naohiro ^b   Yoshizaki, Tomokazu ^b   Murata, Hideyuki ^c   Miwa, Koki ^c   Shoujaku, Hideo ^d   Watanabe, Yukio ^d   Yamada, Nansei ^e   Ito, Yatsuji ^e   Yuta, Atsushi ^f   Takeuchi, Kazuhiko ^f   Hosokawa, Seiji ^g   Mineta, Hiroyuki ^g   Hasegawa, Yasuhisa ^h   Fujimoto, Yasushi ⁱ   Nakashima, Tsutomu ⁱ   Fujieda, Shigeharu ^a   more..

^a UNIVERSITY OF FUKUI   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TOYAMA   (Japan)

^e GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h AICHI CANCER CENTER HOSPITAL   (Japan)

ⁱ NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chubu region of Japan; Epidemiology; NPC

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRUS CAPSID ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CAUSE OF DEATH; COMPARATIVE STUDY; EPIDEMIOLOGICAL DATA; EPSTEIN BARR VIRUS; EYE DISEASE; FEMALE; HEADACHE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; NEUROLOGIC DISEASE; PHARYNX DISEASE; QUESTIONNAIRE; SURVIVAL RATE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, VIRAL; CAPSID PROTEINS; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FEMALE; HEALTH SURVEYS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INCIDENCE; JAPAN; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; SURVIVAL RATE; YOUNG ADULT;

EID: 79151476551     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2010.07.006     Document Type: Article

References (30)

1. Sawaki S. The basic and clinical study of nasopharyngeal carcinoma. Nippon Jibiinkoka Gakkai Kaiho 1979, 82:1345-1351. Japanese.
2. Takeshita H., Furukawa M., Fujieda S., Shoujaku H., Ookura T., Sakaguchi M., et al. Epidemiological research into nasopharyngeal carcinoma in the Chubu region of Japan. Auris Nasus Larynx 1999, 26:277-286.
3. Bay F., Haugen M., Moger T.A., Tretli S., Aalen O.O., Grotmol T. Age-incidence curves of nasopharyngeal carcinoma worldwide: Bimodality in low-risk populations and aetiologic implications. Cancer Epidemiol Biomarkers Prev 2008, 17:2356-2365.
4. Chen M.C., Feng I.J., Lu C.H., Chen C.C., Lin J.T., Huang S.H., et al. The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979-2003). Ann Oncol 2008, 19:1180-1186.
5. Anandan C., Elton R., Hitchings A., Brewster D.H. Nasopharyngeal cancer incidence and survival in Scotland, 1975-2001. Clin Otolaryngol 2008, 33:12-17.
6. Nesic V., Sipetic S., Vlajinac H., Miljus D., Stosic-Divjak S., Jesic S. Incidence of nasopharyngeal carcinoma in Belgrade during the period 1991-2005. Vojnosanit Pregl 2009, 66:473-476.
7. Yap Y.Y., Hassan S., Chan M., Choo P.K., Ravichandran M. Epstein-Barr virus DNA detection in the diagnosis of nasopharyngeal carcinoma. Otolaryngol-Head Neck Surg 2007, 136:986-991.
8. Guo X., Johnson R.C., Deng H., Liao J., Guan L., Nelson G.W., et al. Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int J Cancer 2009, 124:2942-2947.
9. Ling W., Cao S.M., Huang Q.H., Li Y.H., Deng M.Q. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong. Chin J Cancer 2009, 28:57-59.
10. Lu S.J., Day N.E., Degos L., Lepage V., Wang P.C., Chan S.H., et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990, 346:470-471.
11. Yu K.J., Gao X., Chen C.J., Yang X.R., Diehl S.R., Goldstein A., et al. Association of human leukocyte antigens with nasopharyngeal carcinoma in high-risk multiplex families in Taiwan. Hum Immunol 2009, 13.
12. Yu K.J., Hsu W.L., Chiang C.J., Cheng Y.J., Pfeiffer R.M., Diehl S.R., et al. Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan. Int J Cancer 2009, 124:1622-1625.
13. Zheng X., Yan L., Nilsson B., Eklund G., Drettner B. Epstein-Barr virus infection, salted fish and nasopharyngeal carcinoma. Acta Oncologica 1994, 33:867-872.
14. Gallicchio L., Matanoski G., Tao X.G., Chen L., Lam T.K., Boyd K., et al. Adulthood consumption of preserved and nonpreserved vegetables and the risk of nasopharyngeal carcinoma: a systematic review. Int J Cancer 2006, 119:1125-1135.
15. Abdulamir A.S., Hafidh R.R., Abdulmuhaimen N., Abubakar F., Abbas K.A. The distinctive profile of risk factors of nasopharyngeal carcinoma in comparison with other head and neck cancer types. BMC Public Health 2008, 8:400.
16. Chen C.J., You S.L., Lin L.H., Hsu W.L., Yang Y.W. Cancer epidemiology and control in Taiwan: a Brief review. Jpn J Clin Oncol 2002, 32:66-81.
17. d'Espiney Amaro C., Montalvao P., Henriques P., Magalhaes M., Olias J. Nasopharyngeal carcinoma: our experience. Eur Arch Otorhinolaryngol 2009, 266:833-838.
18. Cui C., Liu L., Ma J., Liang S., Tian L., Tang L., et al. Trigeminal nerve palsy in nasopharyngeal carcinoma: correlation between clinical findings and magnetic resonance imaging. Head Neck 2009, 31:822-828.
19. O T.M., Yu G., Hu K., Li J.C. Plasma Epstein-Barr virus immunoglobulin A and DNA for nasopharyngeal carcinoma screening in the United States. Otolaryngol Head Neck Surg 2007, 136:992-997.
20. Chan K.C.A., Lo Y.M.D. Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma. Cancer Biol 2002, 12:489-496.
21. Jiang S.Q., Liu Q. Application of logistic regression in combination with multiple diagnostic tests for auxiliary diagnosis of nasopharyngeal carcinoma. Chin J Cancer 2009, 28:177-180.
22. Chan A.T., Felip E. Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008, 19:81-82.
23. Lee C.C., Ho H.C., Lee M.S., Hsiao S.H., Hwang J.H., Hung S.K., et al. Primary tumor volume of nasopharyngeal carcinoma: significance for survival. Auris nasus Larynx 2008, 35:376-380.
24. Shen C., Lu J.J., Gu Y., Zhu G., Hu C., He S. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy. Laryngoscope 2008, 118:1206-1210.
25. Sheng L., Shui Y., Shen L., Wei Q. Effect of patient-related delay in diagnosis on the extent of disease and prognosis in nasopharyngeal carcinoma. Am J Rhinol 2008, 22:317-320.
26. Xiao W.W., Han F., Lu T.X., Chen C.Y., Huang Y., Zhao C. Treatment outcomes after radiotherapy alone for patients with early-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2009, 74:1070-1076.
27. Oates J.E., Clark J.R., Read J., Reeve N., Gao K., Jackson M., et al. Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2007, 133:533-540.
28. Xia J., Xia K., Feng Y., Tang A., Tang Y., Wu L., et al. The combination of suicide gene therapy and radiation enhances the killing of nasopharyngeal carcinoma Xenographs. J Radiat Res 2004, 45:281-289.
29. Jiang W., Liao Y., Zhao S., Wu B., Zhou R., Wei R., et al. Role of enhanced radiosensitivity and the tumor-specific suicide gene vector in gene therapy of nasopharyngeal carcinoma. J Radiat Res 2007, 48:211-218.
30. Pan J.J., Zhang S.W., Chen C.B., Xiao S.W., Sun Y., Liu C.Q., et al. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosisof advanced nasopharyngeal carcinoma. J Clin Oncol 2009, 27:799-804.